Serum IGF-binding protein-6 and prostate specific antigen in breast cancer

European Journal of Endocrinology

Volumn 140, Issue 2, 1999, Pages 164-168

  Kaulsay, Karmal K ^a   Ng, E H ^b   Ji, C Y ^b   Ho, G H ^b   Aw, T C ^a   Lee, Kok Onn ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROTEINASE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 6;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BIOAVAILABILITY; BREAST CANCER; CONTROLLED STUDY; FEMALE; GEOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOASSAY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; OSMOLAR CONCENTRATION; PROSTATE-SPECIFIC ANTIGEN;

EID: 0033061542     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400164     Document Type: Article

References (34)

1. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Uppman ME et al. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research 1990 50 48-53.
2. Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA, Ramasharma K et al. Insulin-like growth factor II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Molecular Endocrinology 1989 3 1701-1709.
3. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CT Jr et al. Insulin-like growth factor binding protein enhancement of insulin-like growth factor-1 (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast cancer cell line. Journal of Cell Physiology 1994 158 69-78.
4. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B et al. Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet 1998 351 1393-1396.
5. Chan JM, Stampfer MJ, Giovanucci E, Gann PH, Ma J, Wilkinson P et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998 279 563-566.
6. McCusker RH, Camacho-Hubner C, Bayne ML, Cascieri MA & Clemmons DR. Insulin-like growth factor (IGF) binding to human tibroblast and glioblastoma cells, the modulating effect of cell released IGF binding proteins (IGFBPs). Journal of Cell Physiology 1990 144 244-253.
7. McGuire WL, Jackson JG, Figueroa JA, Shimasaki S, Powell DR & Yee D. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. Journal of the National Cancer Institute 1992 84 1336-1341.
8. Figueroa JA, Lee AV, Jackson JG & Yee D. Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop. Journal of Clinical Endocrinology and Metabolism 1995 80 3476-3482.
9. Knauer DJ & Smith GL. Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. Proceedings of the National Academy of Sciences of the USA 1980 77 7252-7256.
10. Gill ZP, Perks CM, Newcomb PV & Holly JM. Insulin-like growth factor binding protein-3 (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. Journal of Biological Chemistry 1997 272 25602-25607.
11. Nickerson T, Huynh H & Pollak M. Insulin-like growth factor binding protein-3 induces apoptosis in MCF-7 breast cancer cells. Biochemical and Biophysical Research Communications 1997 237 690-693.
12. Oh Y, Muller HL, Lamson G & Rosenfeld RG. Insulin-like growth factor (IGF) independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition Journal of Biological Chemistry 1993 268 14964-14971.
13. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC & Rosenfeld RG. Prostate-specitic antigen (PSA) is an insulin-like growth factor binding protein-5 proteast found in seminal plasma. Journal of Clinical Endocrinology and Metabolism 1991 75 1046-1055.
14. Cohen P, Peehl DM, Graves HB & Rosenfeld RG. Biological effects of prostate-specific antigen as an insulin-like growth factor binding protein-3 (IGFBP-3) protease. Journal of Endocrinology 1994 142 407-415.
15. Diamandis EP, Yu H & Sutherland DJA. Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Research and Treatment 1994 32 301-310.
16. Yu H & Diamandis EP. Prostate-specific antigen in milk of lactating women. Clinical Chemistry 1995 41 54-58.
17. Roghani M, Hessenlopp P, LePage P, Ballard A & Binoux M. Isolation from human cerebrospinal fluid with a new insulin-like growth factor-binding protein with a selective affinity for IGF-II. FEBS Letters 1989 255 253-258.
18. Lee KO. Oh Y, Giudice LC, Cohen P, Peehl DM & Rosenfeld RG. Identification of insulin-like growth factor binding protein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma. Journal of Clinical Endocrinology and Metabolism 1994 79 1367-1372.
19. Cullen KJ, Smith HS, Rosen N & Lippman ME. Insulin-like growth factor messenger RNA expression by human fibroblasts from benign and malignant lesions. Cancer Research 1991 51 4978-4985.
20. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A et al. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Research 1988 48 6691-6698.
21. Pekonen F, Nyman T. Ilvesmaki V & Partanen S. Insulin-like growth factor binding proteins in human breast cancer tissue. Cancer Research 1992 52 5204-5207.
22. Manni A, Wei L, Badger B, Zaenglein A, Leighton J, Shimasaki S et al. Expression of messenger RNA for insulin-like growth factors and insulin-like growth factor binding proteins by experimental breast cancer and normal tissue in vivo. Endocrinology 1992 130 1744-1746.
23. Howarth DJ, Aronson IB & Diamandis EP. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues. British Journal of Cancer 1997 75 1646-1651.
24. Lazaris AC, Theodoropoulos GE, Diamantopoulos AK, Anastassopoulos PD & Davaris PS. Immunohistochemical detection of cathepsin-D in low grade breast invasive cancer. Anticancer Research 1997 17 2651-2655.
25. Powell DR, Liu F & Baker BK. Insulin-like growth factor binding protein-6 levels are elevated in serum of children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group. Journal of Clinical Endocrinology and Metabolism 1997 82 2978-2984.
26. Kelley K, Oh Y, Gargosky S, Gucev Z, Matsumoto T, Hwa V et al. Insulin-like growth factor binding proteins (IGFBPs) and their regulatory dynamics. International Journal of Biochemistry and Cell Biology 1996 28 619-637.
27. Corcoran D, Perachiotti A & Darbre PD. Increased autocrine production of insulin-like growth factor-II (IGF-II) alters serum sensitivity of MCF-7 human breast cancer cell proliferation. Cell Proliferation 1996 29 479-493.
28. Bruning PF, van Doom J, Bonfrer JM, Van Noord PA, Korse LM, Linders TC et al. Insulin-like growth factor binding protein-3 is decreased in early-stage operable pre-menopausal breast cancer. International Journal of Cancer 1995 62 266-270.
29. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D & Goodwin PJ. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Research and Treatment 1998 47 111-120.
30. Favoni RE, de Cupis A & Perrotta A. Insulin-like growth factor-I (IGF-I) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: mutual relationship and possible correlations with patients' hormonal status. Journal of Cancer Research and Clinical Oncology 1995 121 674-682.
31. Lonning PE, Helle SI, Johannessen DC, Adlercreutz H, Lien EA. Tally M et al. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients. Clinical Endocrinology 1995 42 23-30.
32. Lewitt MS, Saunders H, Cooney GJ & Baxter RC. Effect of human insulin-like growth factor binding protein-1 on the half-life and action of administered insulin-like growth factor-I in rats. Journal of Endocrinology 1993 136 253-260.
33. Borchert GH & Diamandis EP. Elevated levels of prostate-specific antigen in serum of women with fibroadenomas and breast cysts. Journal of the National Cancer Institute 1997 89 587-588.
34. Melegos DN & Diamandis EP. Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer. Clinical Biochemistry 1996 29 193-200.